CLOSED
GET A PIECE OF PURACLENZ
Show more
Chris Dooley • CEO, Director & Co-Founder
Chris is an accomplished senior executive, entrepreneur, and consultant with more than 25 years of success in SMART consumer product industries. He has held leadership positions with Marvel's toy division, Product Spring, Online Devices and iRobot. Chris led operations, U.S. sales, and marketing for iRobot’s Roomba launch and later established Roomba’s international distribution network in Europe, Canada, Russia, Korea, Japan, and Greater China. Chris is successful serial entrepreneur who has founded 5 startups, invented over 80 consumer products and 15 issued patents.
Chris has a Bachelor of Science in Mechanical Engineering from Villanova University and an MBA from New York University.
Read More
Wendell Minnick • Executive Chairman & Co-Founder
Wendell has an extensive career as a founder, investor, and manager of early-stage companies in the energy/energy tech, materials science/nanotech, software systems, and direct consumer products industries. He has developed and commercialized advanced ceramic and nano-composite material technologies for military and commercial applications, raising more than $500 million in equity investments. His pre-seed investment in UVAIRx, Inc., enabled the advancement of photocatalytic oxidation (PCO) technology and the securing of a U.S. patent.
Wendell received a bachelor’s degree in Business from Principia College and completed MBA studies in International Economics at New York University and the London School of Economics.
Read More
Jerrod Keith • Vice President of R&D
Jerrod spent 10 years as the head of research and development for UVAIRx, Inc., where he was responsible for designing and developing all UVAIRx air purification products. He oversaw UVAIRx products from initial concept design and 3D modeling, to rapid prototyping and patent protection, to design for manufacture and assembly, to product testing. He is the inventor of Puraclenz's reaction core system for the photocatalytic purifiers patent.
Jerrod earned his bachelor’s degree in Environmental Design (Architecture) from the University of Colorado Boulder.
Read More
Puraclenz Holdings, Inc. is the parent corporation of Puraclenz LLC, which is a wholly-owned subsidiary. Puraclenz LLC is the operating entity that was formed on June 25, 2020. The Company later formed Puraclenz Holdings, Inc. on December 29, 2021. All investors in this Reg CF offering will become shareholders of Puraclenz Holdings, Inc., which will be the sole member of Puraclenz LLC. The funds raised from this Reg CF offering and received by Puraclenz Holdings, Inc. will flow to Puraclenz LLC on an as-needed basis.
OVERVIEW
An air purifier redefining the standard of “clean air”
We’re not just another air purifier. Standard air cleaners only trap pathogens that pass through their filter… But us? We clean indoor air and surfaces at the source – destroying viruses, mold and bacteria - what we believe is the premier practice to clean air in today’s world.
With a Puraclenz device, you’re treated like one of NASA’s esteemed astronauts. We use an evolved form of the same technology (photocatalytic oxidation) used to provide clean air to astronauts on the International Space Station. Our products clean the air you breathe using IP-protected innovations.
The last two years of the ongoing global health crisis have created a new need. People are seeking a cost-effective and automatic solution to destroy pathogens mid-air and on surfaces.
It’s not enough to wear masks and wipe down surfaces anymore. Consumers need a product that raises the bar in technology, design, and price.
Model P1500 shown
the problem
We live in a world where pathogens dangerously disrupt every aspect of life. COVID-19 did and (continues to do) more damage than just getting people sick. Businesses closed. Graduations were canceled. Celebrations ruined. In the U.S. alone, there have been over 60 million Covid cases and over 829,000 Covid related deaths.
All types of pathogens, like viruses, bacteria, and mold, can cause major worldwide health issues. They are responsible for serious illnesses and infections, and even allergic reactions. Every year, 2.8 million bacterial infections occur in the U.S., and more than 35,000 people die. Up to 11% of people in the U.S. get the influenza flu annually. Even 93% of chronic sinus infections are attributed to mold. Excessive concentrations of bacteria, viruses, and molds can trigger asthma episodes for 15 million Americans.
People spend nearly 90% of their time indoors, and indoor air pollution is a top concern of the EPA. Typical indoor air contains two to five times more pollutants than outdoor air.
Standard air purifiers clearly aren’t effective enough at destroying these pathogens. HEPA, a standard device, only collects particles that pass through its filter. Then, it uses air changes to clean pathogens in the room.
These air changes take time. Ten to sixty minutes to be exact. By the time the cleaning is finished, people in the space could have already inhaled the pathogens.
the market
Puraclenz is addressing the fast-growing $11.6 billion air purification market. It’s estimated to accelerate to $22.8 billion over the next six years, with a 10% CAGR.
Source: Grand View Research
Industry analysts created those market estimates before COVID-19 started. We can only imagine the elevated market potential since the virus took off and developed its growing number of dangerous variants.
Several companies and technologies compete with us in the Interior Air Quality (IAQ) sector. This sector uses various technologies, including UV light-based systems, hydrogen peroxide, negative ionizers, and more.
Most competitors’ products are considered “passive” devices, which have serious drawbacks:
Only treat air that passes through their device
Less energy-efficient
Regularly require expensive filters changes
Do not clean surfaces
There is a large price range for air purification. UV robots can cost $125,000 and small HEPA products cost $99.99. Our tech exceeds both competing capabilities at a price range between $299 and $499.
Our proprietary technology offers a unique market opportunity for powerful, low-cost, and certified safe air. We believe Puraclenz is the lowest cost professional-grade system.
The company’s patent portfolio protects the advanced PCO design. We have four issued patents and six other pending patents. Plus our mass production process uses trade secrets that allow our purifiers to produce an extraordinarily high density of ions providing an unprecedented competitive advantage in the marketplace.
the solution
Complete air purification through small, inexpensive devices
Puraclenz provides continuous cleaning coverage in large areas with low energy consumption. And it’s easy too. Just plug in the unit, run continuously, and breathe easy knowing any pathogens are being destroyed at the source.
We believe Puraclenz is the next generation of indoor air purification. Our devices use internal UV light that reflects onto a patented titanium catalyst, generating an extraordinarily high density of positive and negatively charged ions. These ions are the heroes–– they cling to and deactivate the pathogens mid-air and on exposed surfaces.
We now sell three purifier models that clean 750, 1,500, or 3,000 square feet areas. Since Puraclenz generates no fumes or harmful chemicals and is certified ozone-free, it’s safe to use around children and pets. Our lab studies also show, when Puraclenz is used in a room, it overwhelmingly halts the growth of mold.
Puraclenz develops, manufactures, and markets its proprietary air purification products to businesses and consumers worldwide. In the U.S., we manage all marketing, sales, and customer support activities directly. We currently sell through three distribution channels.
PCO technology has been safely purifying the air and exposed surfaces for over 40 years. We advanced the power and safety of this technology with our patented cell design. Puraclenz’s design generates an extraordinarily high density of pathogen-destroying ions without producing any harmful by-products. Hand-cleaning or HEPA filters don’t cut it. Our design kills the pollutants they miss.
Why invest
Our numbers speak for themselves. Since we launched in May 2021, Puraclenz has already generated over $700,000 in revenue with thousands of installations. Many universities, luxury hotels, schools, fitness centers, grocery stores, and small businesses nationwide are using Puraclenz to clean their air and surfaces.
*Revenue of the company's subsidiary, Puraclenz, LLC.
We currently sell five SKUs through four distribution channels in the U.S., Canada, and Mexico. In the U.S., Puraclenz sells air purification equipment direct to home, business customers from Puraclenz.com, and in bulk through its team of sales reps and network of distributors. We have master distributor agreements for Canada and Mexico.
Puraclenz has an aggressive five-year growth plan to address this accelerating market. We hope to see annual revenues of $200 million at the end.
In 2022, Puraclenz plans to introduce four more SKUs and expand worldwide distribution to Europe, Japan, India, Southeast Asia, and the Middle East.
We project that U.S. distribution will also expand in the next two years. In 2022, Puraclenz hopes to expand distribution to online marketplaces like Amazon, Walmart.com, Rakuten, and Houzz. In 2023 and 2024, we aim that our products will be sold in home retail stores, such as Best Buy, Target, Bed Bath Beyond, Home Depot, Lowes, and more.
Global concerns of viral spread are growing. Every business and household needs better air purification. Our devices are scientifically proven to proactively reduce viruses mid-air and on exposed surfaces.
We believe Puraclenz’s geographic, application, and technology segmentation offers a large growth potential in the air purification market. Our products are backed by a strong and experienced management team and protected by a global patent portfolio.
This is your chance to participate in a market opportunity with disruptive technology. We’ve created a low-cost product that efficiently addresses what we feel is the biggest global health crisis in over 100 years. It feels good knowing we’re making a difference.
We’re so proud of our success with Puraclenz in just one year. Your investment will push us closer to our ambitious expansion goals in the years to come. Let’s protect people from pathogens and help them breathe easily. Join us!
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
Early Bird
Friends and Family: Invest within the first 72 hours and receive 15% bonus shares.
Super Early Bird: Invest within the first week and receive 10% bonus shares.
Early Bird Bonus: Invest within the first 2 weeks and receive 5% bonus shares.
Volume
Invest $500+: Receive 30% off first purchase (up to $150 retail value)
Invest $1,000+: Receive 1 FREE P750 Purifier ($299 retail value)
Invest $5,000+: Receive 5% bonus shares + Receive 2 FREE Purifiers of your choice (up to $999 retail value)
Invest $10,000+: Receive 7% bonus shares + Receive 3 FREE Purifiers of your choice (up to $1,499 retail value)
Invest $25,000+: Receive 10% bonus shares + Receive 4 FREE Purifiers of your choice (up to $1,999 retail value)
Invest $50,000+: Receive 15% bonus shares + Receive 6 FREE Purifiers of your choice (up to $2,999 retail value)
Invest $100,000+: Receive 20% bonus shares + Receive 8 FREE Purifiers of your choice (up to $4,999 retail value)
*All perks occur when offering is complete.
The 10% StartEngine Owners' Bonus
Puraclenz Holdings, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class B Non-Voting Common Stock at $8.00 / share, you will receive 10 additional shares of Class B Non-Voting Common Stock, meaning you'll own 110 shares for $800. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Insider Investment Notice
Officers, directors, executives, and existing owners with a controlling stake in the company (or their immediate family members) may make investments in this offering. Any such investments will be included in the raised amount reflected on the campaign page.
Irregular Use of Proceeds
06.07.22
06.06.22
Puraclenz®, maker of professional air and surface purifiers that are low-cost and highly effective against dangerous viruses, bacteria, and mold, including SARS-CoV-2, the virus that causes COVID-19, is ending its Regulation Crowdfunding Campaign tomorrow June 7, 2022 at 11:59pm PST.
In addition to enhancing interior air quality, Puraclenz® comes with no chemicals or other additives, making it a low-cost yet effective solution. Puraclenz's founders developed the technology long before the global pandemic, proven to safely reduce viruses and bacteria that thrive in today's conditions. Based on independent efficacy tests, Puraclenz® P3000 is over 99% effective against the MS2 (the proxy virus of SARS-CoV-2) in the air. In a separate lab test, a Puraclenz® P3000 deactivated 95.4% of dangerous bacteria such as MRSA (Methicillin-Resistant Staphylococcus Aureus).
In the future, interior air purification will look much different than it does today with Puraclenz's patented technology. With its revolutionary natural ionization process, the company redefines how we clean and sanitize spaces, creating high-density ions without generating ozone or using harmful chemicals that can be toxic over time, even in small doses. In both large and small public areas such as restaurants, churches, spas, gyms, homes, waiting rooms, and more, Puraclenz fills spaces with natural ions that proactively kill pathogens in the air around them and on exposed surfaces.
"We're excited to offer a low purchase price and low maintenance cost air purification solution to a much larger audience with the help of our new investor partners," says CEO Chris Dooley.
Businesses can reduce their dependence on spray disinfectants by using Puraclenz and saving time and money. This innovation significantly speeds up the reopening process, provides workers with a more comfortable and secure office work environment, and enables customers to use indoor services, such as gyms or spas, where they might feel uneasy following two years.
For more information, visit https://www.startengine.com/puraclenz.
About Puraclenz: Puraclenz is a company focused on health, wellness, and technology. It has reinvented in-flight air purification using PCO (photocatalytic oxidation) technology previously used to purify the air in the International Space Station. Using their proprietary version of this technology, Puraclenz developed a line of powerful, affordable, and certified ozone-free air purifiers to help businesses reopen quickly. The Puraclenz team is motivated by personal experience and science and founded on their own proprietary technology. Puraclenz's mission is to offer consumers low-priced, high-performance interior air and surface purification products for home and the workplace. In addition to a competitive purchase price and low maintenance cost, they also provide a large area of coverage substantially proven effective in multiple independent laboratory tests against dangerous viruses, bacteria, and mold.
06.02.22
New laboratory test results are in! World renown laboratory Eurofins in France conducted a surface test following EN 17272 standards that show a Puraclenz P3000 unit reduced Candida albicans mold by 99.75% inside a large 34.5m3 test chamber. Plates with the live mold spores were placed over 8 feet away from the P3000 device during this test and the Puraclenz unit remotely reduced the pathogen by 99.75% over an 8 hour period.
Ordinary air purifiers cannot destroy pathogens on surfaces like Puraclenz. Get info on investing in Puraclenz: www.startengine.com/puraclenz
05.31.22
Puraclenz's cumulative booked revenue is now over $1 million including purchase orders received.
Get info on investing in Puraclenz: www.startengine.com/puraclenz
04.13.22
Puraclenz is pleased to announce that the United States Patent and Trademark Office
has granted a registered trademark for PURACLENZ
Get info on investing in Puraclenz: www.startengine.com/puraclenz
This important trademark joins the growing intellectual property portfolio owned by Puraclenz summarized below:
04.07.22
Canada Sales are Scaling Up. Puraclenz’s Canadian master distributor Ogena Solutions has issued a new $87,998 purchase order and also provided a forecast to purchase an additional $280,000 in 2022. Sales in Canada began in January 2022 and Ogena Solutions has made great distribution progress in just several months.
Ogena Solutions. In 2021, Puraclenz entered into an exclusive master distribution agreement with Ogena Solutions to sell our commercial line of products in Canada and to USA Animal Health customers. Ogena Solutions has forged an identity as one of the most respected animal health biosecurity companies in North America and over the last several years has been expanding its knowledge and experience into the human health sector. Following a ‘One Health’ philosophy, Ogena Solutions offers innovative, state-of-the-art products and technologies that meet the highest standards for efficacy, efficiency, and safety, providing best-in-class solutions for government agencies, corporations, and small businesses throughout the continent.
Get info on investing in Puraclenz: www.startengine.com/puraclenz
03.31.22
Puraclenz has an investment update. Insiders made investments in the amount of $10,496 in the Company’s current Reg CF offering. Please refer to the offering materials for further information and refer to the Company’s Risk Factors.
03.30.22
As part of the Company’s major effort to reduce its cost of goods sold and maintain our lowest professional grade pricing model, Puraclenz is moving mass production of its P-series products to Vietnam.
This will reduce Puraclenz's manufacturing costs by 25% for every P-series product imported into the USA by eliminating the Section 301 tariff and leveraging lower labor costs in Vietnam. Our CEO Chris Dooley has worked with the owners of our new manufacturer for over 20 years. They are a seasoned and trusted supplier to many Fortune 500 companies. The new Manufacturing Agreement was signed on March 25, 2022 and mass production in Vietnam will start before the end of 2022.
Get info on investing in Puraclenz: www.startengine.com/puraclenz
03.25.22
Puraclenz continues its strong revenue growth. Puraclenz's cumulative booked revenue is now over $885,000 including purchase orders received. The Company currently sells 5 SKU's through 4 channels of distribution in the USA, Canada and Mexico. In the USA, Puraclenz sells air purification equipment direct to home and business customers from Puraclenz.com, and in bulk through its team of sales reps and network of distributors.
Puraclenz’s network of authorized distributors is expanding. In the past month, Puraclenz has signed distribution agreements with 3 new distributors in California, North Carolina and Florida who are selling our products to their commercial clients including health care practitioners, municipal government agencies, non-profit organizations, and office space.
Get info on investing in Puraclenz: www.startengine.com/puraclenz
03.18.22
Our entire team is grateful for the tremendous support to all who have invested in our company thus far! There has been incredible momentum behind the campaign and at the moment of this message we have raised over $100k in investments in just over 1 week!
We will be posting updates here at least once per week to keep you apprised of all of the exciting new developments. You can also join the mailing list on our website and stay in touch on Facebook and Instagram.
Venture Club
Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
Tier 1
Invest $500+: Receive 30% off first purchase (up to $150 retail value)
Tier 2
Invest $1,000+: Receive 1 FREE P750 Purifier ($299 retail value)
Tier 3
Invest $5,000+: Receive 5% bonus shares + Receive 2 FREE Purifiers of your choice (up to $999 retail value)
Tier 4
Invest $10,000+: Receive 7% bonus shares + Receive 3 FREE Purifiers of your choice (up to $1,499 retail value)
Tier 5
Invest $25,000+: Receive 10% bonus shares + Receive 4 FREE Purifiers of your choice (up to $1,999 retail value)
Tier 6
Invest $50,000+: Receive 15% bonus shares +Receive 6 FREE Purifiers of your choice (up to $2,999 retail value)
Tier 7
Invest $100,000+: Receive 20% bonus shares + Receive 8 FREE Purifiers of your choice (up to $4,999 retail value)
0/2500
3 years ago
Show more
1
0
3 years ago
Show more
2
0
3 years ago
Show more
1
0
3 years ago
Show more
1
0
3 years ago
Show more
2
0
3 years ago
Show more
0
0
3 years ago
Show more
1
0
3 years ago
Show more
1
0
3 years ago
Show more
1
1
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
PINNED BY STARTUP
Dave Hachey
3 years ago
My company (www.ogenasolutions.com) has been focused in the biosecurity space for over 17 years and is a well respected provider of biosecurity supplies, protocols and training in animal health. Three years ago we found the people at Puraclenz, have invested in them, and have the following thoughts on HEPA: Although HEPA filters are very good they're definitely not as effective as people are led to believe. Most believe that HEPA filters remove 99.97% of bacteria in an entire room, when in fact that rating is only a measurement of what comes out of the clean side of the filter. The reality is that the 99.97% rating is NOT what a HEPA filter will do for all the air in an average room. If the room is specifically designed for the use of HEPA filters, such as a surgical suite in a hospital where everything, the heating/cooling system, the shape of the room, the placement of the equipment, everything, is designed to ensure that ALL of the air in the room goes through the HEPA filter about 12-20 times/hour, THEN you may achieve 99.97% for the entire room. Unfortunately the spaces we live and work in are not designed for HEPA and do not have anywhere near that number of air changes per hour of all the air in a room (average heating/cooling systems provide 1-2 ACH), and depending on the size of the HEPA system you may get up to 6 ACH. According to ASHRAE (https://www.ashrae.org/), the organization that develops the indoor air quality standards used by the EPA, a properly sized HEPA system placed in the average indoor space will only capture about 50% of the 'particulate' matter (not specifically viruses or bacteria) in the room. To me, this is why we need more, why despite all the measures we take diseases still spread. The EPA has labelled PCO as an 'emerging technology' because although it's been known to be very effective at killing viruses, bacteria and mold, the thing that's held it back from widespread use is that PCO devices have generated unsafe levels of ozone and shouldn't be used around people and animals. The Puraclenz invention is that they've found a way to create a system that increases the level of ions in the air without the use or development of ozone (All Puraclenz systems passed the UL2998 certification test for being an ozone free device). To us, this is one of the biggest breakthrough's in air purification technology in decades, and the bonus is that the ions work on surfaces as well.
Show more
1
0